# Volastra Therapeutics, Inc. — Form D

Volastra Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-23. The offering totals $30.1M, of which $30.1M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-09-23
- Form: D
- Accession: 0001968822-25-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $30.1M
- Amount sold: $30.1M
- Investors: 11
- Date of first sale: 2025-09-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-558375

## Issuer

- Name: Volastra Therapeutics, Inc.
- CIK: 0001968822
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1361 AMSTERDAM AVENUE, NEW YORK, NY, 10027
- Phone: 646-344-1248

## Officers, directors & promoters (26)

_Showing 25 of 26 people._

| Name | Role | Location |
| --- | --- | --- |
| Samuel Bakhoum | Director | NEW YORK, NY |
| Arjun Balar | Director | NEW YORK, NY |
| Luc Dochez | Director | NEW YORK, NY |
| Jill Goldstein | Director | NEW YORK, NY |
| Ellie McGuire | Director | NEW YORK, NY |
| Robert Mittendorff | Director | SAN FRANCISCO, CA |
| David Nicholson | Director | Carlsbad, CA |
| Sandra Peterson | Director | NEW YORK, NY |
| David Southwell | Director | NEW YORK, NY |
| David Southwell | Executive Officer | NEW YORK, NY |
| Amy Schulman | Director | Cambridge, MA |
| Sandra Peterson | Executive Officer | NEW YORK, NY |
| Arjun Zolot Balar | Director | New York, NY |
| Stefan Zolot Vitorovic | Director | New York, NY |
| Eileen Zolot McGuire | Director | New York, NY |
| Rachel Zolot Schwartz | Executive Officer | New York, NY |
| Samuel Zolot Bakhoum | Director | New York, NY |
| Scott Drutman | Executive Officer | New York, NY |
| Charles Hugh-Jones | Director | New York, NY |
| Charles Hugh-Jones | Executive Officer | New York, NY |
| David Zolot Nicholson | Director | New York, NY |
| Sandra Zolot Peterson | Director | New York, NY |
| Rez Zolot Halze | Director | New York, NY |
| Diane Tager | Executive Officer | New York, NY |
| Michael Su | Executive Officer | New York, NY |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-05-30](https://search.stillhousedata.com/formd/0001968822-24-000001) | D | $15.0M | $15.0M |
| [2023-03-13](https://search.stillhousedata.com/formd/0001968822-23-000001) | D | $60.2M | $60.2M |

## More

- [CIK 1968822 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1968822&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001968822-25-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.